The dopamine D 4 receptor antagonist L-745,870: effects in rats discriminating cocaine from saline

By Costanza R.M.   Terry P.  

European Journal of Pharmacology, Vol. 345, Iss. 2, 1998-03 ,pp. : 129-132

Elsevier

Access to resources Recommend Favorite

FAUC 213, a highly selective dopamine D₄ receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia

By Boeckler Frank   Russig Holger   Zhang Weining   Löber Stefan   Schetz John   Hübner Harald   Ferger Boris   Gmeiner Peter   Feldon Joram  

Psychopharmacology, Vol. 175, Iss. 1, 2004-08 ,pp. : 7-17

Springer Publishing Company

Access to resources Recommend Favorite

The antipsychotic potential of l-stepholidine—a naturally occurring dopamine receptor D₁ agonist and D₂ antagonist

By Natesan Sridhar   Reckless Greg   Barlow Karen   Odontiadis John   Nobrega José   Baker Glen   George Susan   Mamo David   Kapur Shitij  

Psychopharmacology, Vol. 199, Iss. 2, 2008-08 ,pp. : 275-289

Springer Publishing Company

Access to resources Recommend Favorite

Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects

By Kohn Y.   Ebstein R.P.   Heresco-Levy U.   Shapira B.   Nemanov L.   Gritsenko I.   Avnon M.   Lerer B.  

European Neuropsychopharmacology, Vol. 7, Iss. 1, 1997-02 ,pp. : 39-43

Elsevier

Access to resources Recommend Favorite

Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor

By Wood M.D.   Boyfield I.   Nash D.J.   Jewitt F.R.   Avenell K.Y.   Riley G.J.  

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite